Expression and roles of poly(ADP-ribose) polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues

Pu Jing; Li Xun; Zhu Jun; Bai ZhongTian; Yan Jun

doi:10.3969/j.issn.1001-5256.2016.02.029

Issue 2

Feb. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(2): 337-341

PDF( 1892 KB)

Expression and roles of poly(ADP-ribose) polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues

DOI: 10.3969/j.issn.1001-5256.2016.02.029

Third Department of General Surgery,The Second People's Hospital of Lanzhou

Received Date: 2015-06-04
Published Date: 2016-02-20

Abstract

Abstract

Objective To investigate the protein expression of poly( ADP- ribose) polymerase- 1( PARP- 1) and caspase- 3 in pancreatic cancer and adjacent tissues. Methods A total of 66 cancer tissue samples and 113 samples of adjacent tissues were collected from the patients who underwent surgical treatment with a confirmed diagnosis of pancreatic cancer by postoperative pathological examinations in The First Hospital of Lanzhou University from January 2013 to June 2014,and immunohistochemical examinations were performed to measure the expression of PARP- 1 and caspase- 3 in these samples. The chi- square test was applied for comparison of categorical data between groups. Results Of all the 66 samples of pancreatic cancer,53 had varying degrees of PARP- 1 expression,with a positive rate of80. 3%; of all the 133 samples of adjacent tissues,39 had PARP- 1 expression,with a positive rate of 34. 5%; the expression of PARP-1 in the samples of pancreatic cancer was significantly higher than that in the samples of adjacent tissues( χ2= 34. 79,P < 0. 01). The expression of PARP- 1 in moderately and poorly differentiated samples of pancreatic cancer( 18 /25,72%; 10 /14,71. 4%) was significantly higher than that in highly differentiated samples( 3 /14,21. 4%)( χ2= 10. 76,P < 0. 01). Of all the 66 samples of pancreatic cancer,47 had varying degrees of caspase- 3 expression,with a positive rate of 71. 2%; of all the 133 samples of adjacent tissues,71 had caspase-3 expression,with a positive rate of 62. 8%. The expression of caspase- 3 in highly differentiated samples of pancreatic cancer( 11 /18,61. 1%) was significantly higher than that in moderately and poorly differentiated samples( 4 /20,20%; 0 /9,0)( χ2= 11. 44,P < 0. 01).Conclusion The expression level of PARP- 1 in the samples of pancreatic cancer is significantly higher than that in the samples of adjacent tissues,and the strong positive rate of PARP- 1 increases with the decrease in the degree of differentiation; the expression of caspase- 3 is similar between pancreatic cancer and adjacent tissues,and the strong positive rate of caspase- 3 decreases with the decrease in the degree of differentiation. The expression levels of PARP- 1 and caspase- 3 may be related to the development and progression of pancreatic cancer.
- pancreatic neoplasms,
- poly(ADP-ribose) polymerases,
- caspase 3

FullText(HTML)

References(19)

References

[1] TAN J.Analysis of the lastest incidence and fatality rate of tumors in China and the rest of the world[R].Chin Cancer Registry Annu Rep,2013.(in Chinese)谭健.中国和全球最新肿瘤发病率和死亡率解析[R].中国肿瘤登记年报,2013.

[2]FENG JJ,JIA GZ,TAN GY,et al.Changes of serum level of carbohydrate antigen CA19-9 in patients with liver diseases and its clinical significance[J].The J Pract Med,2008,25(9):1043-1044.(in Chinese)逢金聚,贾桂芝,谭国英,等.肝病患者肿瘤标记物CA199水平变化及其临床意义[J].实用医学杂志,2008,25(9):1043-1044.

[3]KIEBACK DG.Adenovirus-mediated thymidine kinase gene therapy induces apoptosis in human epithelial O-varian cancer cells and damages PARP-1[J].In Vivo,2009,23(1):77-80.

[4]CHO BB,TOLEDO-PEREYRA LH.Caspase-independent programmed cell death following ischemic stroke[J].J Invest Surg,2008,21(3):141-147.

[5]NOSHO K,YAMAMOTO H,MIKAMI M,et al.Overexpression of poly(ADP-ribose)polymerase-1(PARP-1)in the early stage of colorectal carcinogenesis[J].Eur J Cancer,2006,42(14):2374-2381.

[6]OSSOVSKAYA V,KOO IC,KALDJIAN EP,et al.Upregulation of poly(ADP-ribose)polymerase-1(PARP-1)in triple-negative breastcancer and other primary human tumor types[J].Genes Cancer,2010,1(8):812-821.

[7]LI Y,WEI W,LYU SQ,et al.Effects of PARP-1 on angiogenesis of ovarian cancer[J].J Shandong Univ:Health Sciences,2014,52(4):97-106.(in Chinese)李燕,尉蔚,吕树卿,等.PARP-1对卵巢癌血管生成的影响[J].山东大学学报:医学版,2014,52(4):97-106.

[8]NOMURA F,YAGUCHI M,TOGAWA A,et al.Enhancement of polyadenosine diphosphate ribosylation in human hepatocellular carcinoma[J].Gastroenterol Hepatol,2000,15(7):529-535.

[9]FREDERICK K,MORITZVON W,ALBRECHT S,et al.High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer[J].Histopathology,2012,61(6):409-416.

[10]XIE QX,LIN XC,HAN CX,et al.Significance of Caspase-3 expression in renal cell cancer[J].China Med Eng,2005,13(5):486-488.(in Chinese)谢庆祥,林吓聪,韩聪祥,等.Caspase-3在肾细胞癌中的表达及其意义[J].中国医学工程,2005,13(5):486-488.

[11]WINTER NR,KRAMER A.Loss of Caspase-1 and Caspase-3 protein expression in human prostate cancer[J].Cancer Res,2001,61(10):1277-1232.

[12]WANG CY,MENG LX,DING ZJ.Expression of PTEN,Survivin and Caspase-3 in human esophageal squmous carcinoma[J].J Mod Oncol,2015,23(4):493-496.(in Chinese)王传艳,孟令新,丁兆军.PTEN、Survivin和Caspase-3在食管鳞癌中的表达[J].现代肿瘤医学,2015,23(4):493-496.

[13]LONG H,WU QM,MA SL,et al.Expression of Midkine and Caspase-3 and their relationship with apoptosis in pancreatic cancer[J].World Chin J Dig,2008,16(35):4015-4019.(in Chinese)龙辉,吴清明,马松林,等.Midkine和Caspase-3在胰腺癌中的表达与细胞凋亡的关系[J].世界华人消化杂志,2008,16(35):4015-4019.

[14]DU Y,FENG YZ,LI F.Expression of livin and caspase-3 and their clinical significance in pancreatic carcinoma[J].Chin J Clin Exp Pathol,2009,25(6):610-614.(in Chinese)杜缘,冯一中,李峰.胰腺癌中livin、caspase-3的表达及其临床意义[J].临床与实验病理学杂志,2009,25(6):610-614.

[15]KOH DW,DAWSON TM,DAWSON VL.Mediation of cell death by poly(ADP-ribose)polymerase-1[J].Pharmacol Res,2005,52(1):5-14.

[16]SUI WY,CHEN CY,LUO ZY,et al.The expression of PAPR-1 and Caspase-3 in human breast cancer and their clinical significance[J].J Univ Sourth China:Med Edit,2010,38(2):210-213.(in Chinese)眭文妍,陈春燕,罗招阳,等.PARP-1和Caspase-3在乳腺癌组织中的表达及临床意义[J].南华大学学报:医学版,2010,38(2):210-213.

[17]GAO J,CHEN HL.Caspase-3,PARP proteins expression and their significances in human lung cancer[J].J Mathematical Med,2006,19(1):34-36.(in Chinese)高俊,陈洪雷.Caspase-3、PARP蛋白在肺癌组织中的表达及临床意义[J].数理医药学杂志,2006,19(1):34-36.

[18]QI SQ,DE S,LI DM,et al.Expressions of PARP-1,Caspase-3,survivin and Bax in cervical squamous cell carcinoma tissues and their clinical significances[J].J Jilin Univ:Med Edit,2013,39(3):512-516.(in Chinese)齐斯琴,德胜,李冬梅,等.子宫颈鳞癌组织中PARP-1、Caspase-3、survivin和Bax的表达及其临床意义[J].吉林大学学报:医学版,2013,39(3):512-516.

[19]HU SM,ZHANG SD,HAO YP,et al.Expressions and significance of PARP-1 and Caspase-3 in colorectal neoplasms[J].Chin J Gastroenterol,2009,14(2):83-87.(in Chinese)胡顺明,张世栋,郝艳萍,等.PARP-1和Caspase-3在结直肠肿瘤中的表达和意义[J].胃肠病学,2009,14(2):83-87.

Relative Articles

[1]	Lou Xin, Gao YuFeng, Ye Jun, Wang YinQiu, Guan ZiShu, Zou GuiZhou. Clinical effect of pegylated interferon α-2a in treatment of previously untreated HBeAg-positive chronic hepatitis B patients and related predictive factors[J]. Journal of Clinical Hepatology, 2018, 34(5): 995-1000. doi: 10.3969/j.issn.1001-5256.2018.05.014
[2]	Yang PuJuan, Huang Yi, Liu HuaBao. Research advances in the association between interleukin-17 and liver diseases[J]. Journal of Clinical Hepatology, 2017, 33(9): 1810-1814. doi: 10.3969/j.issn.1001-5256.2017.09.041
[3]	Li KeXin, Zang MengYa, Wang DongMei, He Huan, Wang YuTing, Qu ChunFeng. Effect of interleukin-17A on stemness of hepatoma cell lines[J]. Journal of Clinical Hepatology, 2017, 33(6): 1131-1136. doi: 10.3969/j.issn.1001-5256.2017.06.023
[4]	Gao Na, Wu RuiHong, Wang XiaoMei, Niu JunQi. Value of HBsAg quantification in predicting the prognosis of patients with chronic severe hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(4): 695-699. doi: 10.3969/j.issn.1001-5256.2016.04.017
[5]	Wang Wei, Rong Jun, Li LiHua, Niu HongYao, Gao HengBo, Zheng HuanWei. Association between dynamic changes in HBsAg and progression of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(6): 1204-1206. doi: 10.3969/j.issn.1001-5256.2016.06.044
[6]	Zhang HaiYue, Zhou Pei, Gong ZuoJiong. Predictive value of HBs Ag quantification in pegylated interferon therapy for chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(5): 977-980. doi: 10.3969/j.issn.1001-5256.2016.05.041
[7]	Li XiaoTian, Yin Yan, Guo YongZe, Zhou LiYun, You ZiXuan. Mechanism of action of 1,25(OH)_2D_3 in influencing the expression of interleukin-17 and macrophage inflammatory protein-3α and inhibiting the formation of liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2016, 32(12): 2331-2336. doi: 10.3969/j.issn.1001-5256.2016.12.020
[8]	Hao TingTing, Ma XiaoPeng, Wen YanLi, Dai GuangRong, Feng YiChao, Zhang Li. Changes in serum levels of M30,M65,and IL-17 and their clinical significance in patients with acute pancreatitis[J]. Journal of Clinical Hepatology, 2016, 32(2): 329-332. doi: 10.3969/j.issn.1001-5256.2016.02.027
[9]	Li HuoYan, Yang ZhaoHui, Ma LiLi, Ma Long. Clinical efficacy of telbivudine and interferon in treatment of HBe Ag-positive chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2015, 31(4): 526-529. doi: 10.3969/j.issn.1001-5256.2015.04.012
[10]	Xian YongChao, Cheng ShuQuan, Ni Hui, Huang ChengJun. Analysis of hepatic CD4~+,CD8~+,CD20~+,and CD57~+ T lymphocytes in chronic hepatitis B patients with different HBe Ag status[J]. Journal of Clinical Hepatology, 2015, 31(4): 546-550. doi: 10.3969/j.issn.1001-5256.2015.04.017
[11]	Liu ZhiHua, He HaiTang, Hu Jing, Fu QunXiang, Luo KangXian. Efficacy of pegylated interferon α-2a in HBe Ag-negative chronic hepatitis B patients and its influencing factors[J]. Journal of Clinical Hepatology, 2015, 31(5): 697-701. doi: 10.3969/j.issn.1001-5256.2015.05.016
[12]	Li CaiDong, Yang YongWei, Li HuiJun, Tian PengFei, Wu Bin. Changes in peripheral plasma concentrations of macrophage migration inhibitory factor,interleukin-17,and interleukin-10 and their correlations with HBV DNA load in chronic HBV carriers[J]. Journal of Clinical Hepatology, 2015, 31(5): 702-705. doi: 10.3969/j.issn.1001-5256.2015.05.017
[13]	Wu Qin, Meng FanPing, Ma XueMei, Jin Bo, Shen LiJun, Wu LiBing, Chu JinDong, Lai WenHui, Han JingJing, Li HanWei. Analysis of association between different HCV genotypes and serum interleukin-17, interleukin-6, and vitamin D in patients with HCV-related cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1849-1852. doi: 10.3969/j.issn.1001-5256.2015.11.019
[14]	Guan HaiTao, Zhao JinLi, Tang Rui, Sun LinLin. IL-17 promotes expression of fibrosis-related factors in hepatic stellate cells[J]. Journal of Clinical Hepatology, 2013, 29(5): 370-374.
[15]	Wu YinYa, Tan ShanZhong, Zhao Lei, Sun WeiWei, Shen JianJun, Liang ZhongFeng. The changes and value of the proportion of CD4+CD25+ regulatory T cells in HBeAg (+) and HBeAg (-) ASC in peripheral blood[J]. Journal of Clinical Hepatology, 2012, 28(3): 209-211.
[16]	Yang ZhiYong, Yang Qian, Xiao GuiBao, Zhao HeHong, Feng Ping. Clinical observation of the relation between the HBeAg and HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2012, 28(4): 270-272.
[17]	Qin JianJie, Lu: Ling. The role and molecular mechanism of interleukin-17 in organ transplant rejection[J]. Journal of Clinical Hepatology, 2012, 28(11): 812-814.
[18]	Wu YuZhuo. Correlation analysis of quantitative HBsAg and liver histological features of HBeAg-negative chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 923-925.
[19]	Jin Rui, Zhang ShiBin, Bian XinQu, Lu ChengZhen, Liu ZhongSheng, Guo XinHui. Clinical study of IFNα-2b alone or in combination with lamivudine for HBeAg positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 617-619.
[20]	Yao QinJiang, Ma WeiGuo. Therapeutic efficacy of telbivudine in hepatitis B e antigen positive chronic hepatitis B patients with high baseline alanine aminotransferase levels[J]. Journal of Clinical Hepatology, 2011, 27(6): 614-616.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	粟雨萌，张鸣杰，谈振华，谢平. 胰十二指肠切除术后发生胃排空延迟的危险因素分析. 肝胆胰外科杂志. 2024(10): 608-611+616 .
2.	张苗苗，白纪刚，张东，雷建军，耿智敏，冯爱芳，董芳芳，史爱华，吕毅，严小鹏. 用于胰十二指肠切除术中Braun吻合磁环的设计及临床应用. 中国医疗设备. 2022(06): 8-11 .
3.	李利平，游意莹，沈宁，曹宏，王艳玲. 改良内陷式胰肠吻合在胰十二指肠切除术中的应用. 中华肝脏外科手术学电子杂志. 2022(05): 458-462 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (544) PDF downloads(225)

Expression and roles of poly(ADP-ribose) polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues

DOI: 10.3969/j.issn.1001-5256.2016.02.029